Adeeb Aghdassi, MD
Interventional Cardiology · Manassas, VANPI 1346509700
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Abbott at 33.3% of the total.
Across 171 payments — averaging $74.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$4K
- Penumbra, Inc.$1K
- Shockwave Medical, Inc$357
- Novo Nordisk$352
- Heartflow, Inc.$228
- plus $3K from 32 others
What the payments were for
- Travel & lodging$5,80546%
- Food & beverage$6,56452%
- Education$3393%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $4,232 |
| Medtronic | 37 | $3,624 |
| Penumbra, Inc. | 6 | $1,021 |
| Shockwave Medical, Inc | 7 | $357 |
| Novo Nordisk | 6 | $352 |
| Heartflow, Inc. | 3 | $228 |
| Novartis | 10 | $216 |
| Scpharmaceuticals Inc. | 6 | $208 |
| E.r. Squibb & Sons, L.L.C. | 5 | $201 |
| Abiomed | 6 | $188 |
| Bridgebio Pharma, Inc. | 2 | $169 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $150 |
| Edwards Lifesciences | 1 | $137 |
| Boston Scientific | 4 | $135 |
| Philips North America LLC | 1 | $128 |
| Biosense Webster, Inc. | 1 | $127 |
| Ionis Pharmaceuticals, Inc. | 1 | $122 |
| Amgen | 6 | $121 |
| Bayer | 1 | $119 |
| Merck | 6 | $116 |
| Astellas Pharma US Inc | 1 | $100 |
| AstraZeneca | 1 | $99 |
| Angiodynamics, Inc. | 4 | $75 |
| Cardiovascular Systems Inc. | 1 | $60 |
| Johnson & Johnson | 3 | $59 |
| Pfizer | 2 | $44 |
| Boehringer Ingelheim | 2 | $39 |
| Silk Road Medical, Inc. | 1 | $38 |
| Terumo Medical Corporation | 1 | $31 |
| Cvrx, Inc. | 2 | $30 |
| Recor Medical Inc | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| W. L. Gore & Associates, Inc. | 1 | $26 |
| Cook Medical LLC | 2 | $26 |
| Coopersurgical, Inc. | 2 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$1,650
- Resolute$1,601
- Indigo System$979
- ESPRIT$818
- SUPERA$608
- COREVALVE EVOLUT R$525
- FFRct$226
- Attruby$144
- Xience Sierra Coronary Stent System$144
- QUADRA ASSURA$140
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$137
- US Und$128
- Carto 3$127
- AVEIR$126
- CAMZYOS$125
- TRYNGOLZA$122
- FUROSCIX$122
- Ozempic$119
- Kerendia$119
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$112
How this compares
$12,709 in reported general payments places this provider in the 70th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $86,093 |
| EntrestoSacubitril/Valsartan | 11 | $21,791 |
| XareltoRivaroxaban | 11 | $15,261 |
| BrilintaTicagrelor | 17 | $14,300 |
| Atorvastatin Calcium | 104 | $979 |
| Prasugrel Hcl | 11 | $963 |
| ClopidogrelClopidogrel Bisulfate | 100 | $957 |
| Rosuvastatin Calcium | 39 | $670 |
| Metoprolol Succinate | 29 | $441 |
| Metoprolol Tartrate | 75 | $338 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 25 | $309 |
| Amlodipine Besylate | 44 | $266 |
| Carvedilol | 33 | $253 |
| Hydralazine Hcl | 11 | $154 |
| Lisinopril | 26 | $132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $44 | $86,09370 claims |
| NovartisEntresto | $216 | $21,79111 claims |
| Johnson & JohnsonXarelto | $59 | $15,26111 claims |
| AstraZenecaBrilinta | $99 | $14,30017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 176 interventional cardiology providers in Virginia.
Other interventional cardiology in Manassas
- Ashkan KarimiManassas$60K
- Deepak TalrejaVirginia Beach$1.5M
- Rajiv TayalFredericksburg$984K
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
- Wayne BatchelorFalls Church$196K
- Matthew SherwoodFalls Church$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.